ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Orlando, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near Orlando, FL, USA:

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer. (BRIA-ABC)

Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...

Enrolling
Breast Cancer
Breast Neoplasm
Drug: Cyclophosphamide
Drug: Interferon infiltration of the inoculation site

Phase 3

BriaCell Therapeutics

Orlando, Florida, United States and 35 other locations

A phase 1b study to assess the combination of ARV-471 and everolimus in participants with advanced or metastatic ER+/HER2- breast cancer...

Active, not recruiting
Breast Cancer
Drug: ARV-471 in combination with Everolimus

Phase 1

Arvinas
Arvinas

Lake Mary, Florida, United States and 8 other locations

breast biopsy occurs if biopsy is needed....

Enrolling
Breast Cancer
Device: Digital Mammography
Device: CBBCT Imaging
Koning Health

Port Orange, Florida, United States and 3 other locations

A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd...

Enrolling
HER2 Positive Metastatic Breast Cancer
Drug: ARX788

Phase 2

Ambrx

Orlando, Florida, United States and 62 other locations

to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...

Active, not recruiting
Estrogen Receptor Positive Breast Cancer
HER-2 Positive Breast Cancer
Drug: palbociclib
Drug: trastuzumab

Phase 3

Alliance Foundation Trials

Orlando, Florida, United States and 117 other locations

postmenopausal women with locally advanced or metastatic ER+/HER2- breast cancer with an acquired ESR1 mutation and who have diseas...

Active, not recruiting
Locally Advanced or Metastatic Breast Cancer
Drug: Lasofoxifene
Drug: Fulvestrant

Phase 2

Sermonix Pharmaceuticals

Winter Haven, Florida, United States and 50 other locations

positive (HR+) and human epidermal growth factor 2 negative (HER2-) breast cancer (BC) and other advanced solid tumors. Th...

Enrolling
Hormone-receptor-positive Breast Cancer
Non-small Cell Lung Cancer
Drug: BGB-43395
Drug: Fulvestrant

Phase 1

BeiGene
BeiGene

Lake Mary, Florida, United States and 64 other locations

ARV-471 (PF-07850327) given together with palbociclib in advanced breast cancer. In particular, the study will compare the combinat ...

Active, not recruiting
Breast Cancer
Drug: Letrozole
Drug: ARV-471 (PF-07850327)

Phase 3

Pfizer
Pfizer

Orange City, Florida, United States and 40 other locations

A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....

Active, not recruiting
Advanced Breast Cancer
Drug: ARV-471
Drug: Fulvestrant

Phase 3

Pfizer
Pfizer

Orlando, Florida, United States and 446 other locations

oral immuno-oncology product candidate targeting immune-suppressive tumor-associated myeloid cells through selective inhibition of phosphoin...

Active, not recruiting
Breast Cancer
Renal Cell Carcinoma
Drug: nab-paclitaxel
Drug: Bevacizumab

Phase 2

Infinity Pharmaceuticals
Infinity Pharmaceuticals

Orlando, Florida, United States and 23 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems